Bringing doctors together

or

A free, private network for verified physicians

Leading voices

Dr. John Stafford

General Endocrinology · OSUMC

View

Dr. Melina Manolas

General Endocrinology · WCM

View

Dr. Marisa Cruz

General Endocrinology · UCSF

View

Dr. Austin Baraki

Obesity Medicine · Vineyard Health

View

Dr. Maria Fleseriu

Neuroendocrinology · OHSU Hospital

View

Dr. Priya Jaisinghani

Obesity Medicine · NYU Langone

View

Dr. David Cohen

Thyroid · RU

View

Dr. Susan Spratt

Diabetes · Duke

View

Dr. James Findling

Adrenal Diseases · Froedtert

View

Dr. Anupam Kotwal

Thyroid · UNMC

View
  • Discover your community

  • Stay current

  • A profile that represents you

  • Find your people

About RoonPrivacyTerms
    OHDr. Ole-Petter Hamnvik

    Dr. Ole-Petter Hamnvik

    Endocrinology · General Endocrinology
    Brigham and Women's Hospital
    olepetter

    Research

    Management of vasomotor symptoms in cancer patients.

    2025

    Via The oncologist

    Research

    Methodology Concerns Regarding Claims Data Studies in Transgender Health.

    2025

    Via JAMA oncology

    Research

    A Smooth Transition.

    2025

    Via The New England journal of medicine

    Research

    Breast cancer in a transgender man.

    2025

    Via CA: a cancer journal for clinicians

    Research

    Injectable Estradiol Monotherapy Effectively Suppresses Testosterone in Gender-Affirming Hormone Therapy.

    2025

    Via Endocrine practice

    Research

    Comparing radiologically evident injuries among cisgender and transgender women.

    2025

    Via Injury prevention

    Research

    Consensus-based disease definitions for endocrine immune-related adverse events of immune checkpoint inhibitors.

    2025

    Via Journal for immunotherapy of cancer

    Research

    Clinical outcomes and safety of immune checkpoint inhibitors in patients with solid tumors and paraneoplastic syndromes.

    2024

    Via Journal for immunotherapy of cancer

    Research

    The Use of Injectable Estradiol in Transgender and Gender Diverse Adults: A Scoping Review of Dose and Serum Estradiol Levels.

    2024

    Via Endocrine practice

    Research

    Revisiting Injectable Estrogen Dosing Recommendations for Gender-Affirming Hormone Therapy.

    2024

    Via Transgender health

    Research

    Injectable Estradiol Use in Transgender and Gender-Diverse Individuals throughout the United States.

    2024

    Via The Journal of clinical endocrinology and metabolism

    Research

    Dearth of ICD Codes for Complications of Immune Checkpoint Inhibitors Impedes Clinical Care and Research.

    2023

    Via Journal of the Endocrine Society

    Research

    Cancer surveillance for transgender and gender diverse patients with Lynch syndrome: a practice resource of the Collaborative Group of the Americas on Inherited Gastrointestinal Cancer.

    2023

    Via Familial cancer

    Research

    Associations between immune-related thyroid dysfunction and efficacy of immune checkpoint inhibitors: a systematic review and meta-analysis.

    2022

    Via Cancer immunology, immunotherapy

    Research

    Bone Health and Denosumab Discontinuation in Oncology Populations.

    2022

    Via The oncologist